Arrowhead (ARWR) is trading -0.58 percent lower on Monday 26th of October and has a trading volume of USD 50.6 mn
Arrowhead (ARWR) shares dip 12% YoY, trading near $58.98; biotech firm targets gene‑silencing therapies with a $8.2 bn market cap.
- ARROWHEAD PHARMACEUTICALS IN
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read